Most supplement brands are legally hiding how little active ingredient is in your capsule - checking takes 60 seconds
IndustryJanuary 20255 min read

Most supplement brands are legally hiding how little active ingredient is in your capsule - checking takes 60 seconds.

The supplement you're taking might contain a tenth of the dose shown on the label. Legally. The manufacturer isn't lying - they're exploiting a loophole so widely used it has its own industry term. Here's how it works, and how to never fall for it again.

In the European Union and the United States, food supplement regulations require that manufacturers list all ingredients and their quantities on the label. There is, however, a widely exploited exemption: if a manufacturer designates a group of ingredients as a "proprietary blend" or "complex," they are required only to disclose the total weight of the blend - not the individual ingredient quantities within it.

This is not a minor technical detail. It is the primary mechanism by which the supplement industry sells underdosed products at a premium.

The mathematics of a proprietary blend

Consider a label listing: "Cognitive Performance Blend: 750 mg - Lion's Mane Extract, Bacopa Monnieri, Phosphatidylserine, Huperzine A." The clinically-effective dose of Bacopa Monnieri from the RCT literature is 300–450 mg/day. The effective dose of Phosphatidylserine is 100–300 mg/day. Together, these two ingredients require at least 400 mg at minimum effective doses. The total blend is 750 mg.

This sounds like it might work. But Lion's Mane is listed first - under EU regulations, ingredients within a blend must be listed in descending order of weight. If the manufacturer has used 600 mg of Lion's Mane (the cheapest ingredient), that leaves 150 mg for the remaining three actives. Bacopa is now at perhaps 80 mg - less than a quarter of the dose used in the trials that showed cognitive effects. Phosphatidylserine may be present at 30 mg - a tenth of the clinical dose.

The consumer has no way to know this from the label. Everything disclosed is technically accurate.

Four ways to identify underdosing

1. Look for disclosed individual doses. If a product lists each ingredient with its specific quantity (e.g., "Bacopa Monnieri Extract 300 mg, Phosphatidylserine 200 mg"), the manufacturer is being transparent. This is the baseline standard.

2. Cross-reference total blend weight against known clinical doses. If you know the effective dose of each ingredient in a blend and the total weight cannot accommodate all of them at minimum effective levels, at least some are underdosed.

3. Check for standardisation disclosures. "Ashwagandha Root Extract" is not the same as "KSM-66 Ashwagandha Root Extract, standardised to 5% withanolides." Standardisation to a specific active compound percentage is how you verify that the extract resembles what was tested in clinical trials.

4. Be sceptical of very long ingredient lists at low total weights. A 300 mg blend listing 12 ingredients cannot contain any of them at a clinically-meaningful dose. Formulas with fewer, precisely-dosed actives are almost always better than those with impressive-looking but underdosed lists.

Why we disclose everything

Every ingredient in every knowing more. formula is listed individually with its exact dose. We do not use proprietary blends. We do not hide behind "complexes" or "matrices." If you cannot verify that our doses match the clinical literature, we have failed at transparency - and transparency is the only meaningful standard in this category.

← Back to Journal